Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: A clinicopathological study

Figure 3 Evaluating the prognostic significance of pSMAD3L(S204) and VEGFR-1 expression in gastric cancer subgroups. A-I: Kaplan-Meier analysis revealed that higher pSMAD3L(S204) expression was associated with shorter overall survival (OS) in several subgroups of gastric cancer (GC) patients, including T1/T2 (A), T3/T4 (B), N1/2 (C), N3/4 (D), M0 (E), Grade I/II (F), Grade III/IV (G), Clinical stage I/II (H), and Clinical stage III/IV (I); J-N: Moreover, higher VEGFR-1 expression was associated with shorter OS in subgroups of GC patients with T3/T4 (J), N3/4 (K), M0 (L), Grade III/IV (M), and Clinical stage III/IV (N).